These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8133541)

  • 21. Screening for breast cancer. U.S. Preventive Services Task Force, Washington, D.C.
    Am Fam Physician; 1989 Jun; 39(6):89-96. PubMed ID: 2658519
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of National Cancer Institute revised mammography screening guidelines on women 40-49.
    Morton E; Tambor E; Rimer BK; Tessaro I; Farrell D; Siegler IC
    Womens Health Issues; 1996; 6(5):246-54. PubMed ID: 8870503
    [No Abstract]   [Full Text] [Related]  

  • 23. Omissions of the U.S. Preventive Services Task Force.
    Zuurbier RA
    Radiology; 2011 Apr; 259(1):305; author reply 305-6. PubMed ID: 21436102
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer screening: success amid conflict.
    Leitch AM
    Surg Oncol Clin N Am; 1999 Oct; 8(4):657-72, vi. PubMed ID: 10452933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stat bite: Effect of breast cancer awareness month on mammography use.
    J Natl Cancer Inst; 2005 Oct; 97(20):1493. PubMed ID: 16234559
    [No Abstract]   [Full Text] [Related]  

  • 26. Statement on recommendations of the Consensus Development Panel on breast cancer screening.
    J Natl Cancer Inst; 1978 Jun; 60(6):1523-4. PubMed ID: 580622
    [No Abstract]   [Full Text] [Related]  

  • 27. Mammographic screening trials for women aged under 50.
    Furnival CM; Hirst C
    Med J Aust; 1995 Oct; 163(7):384-5. PubMed ID: 7565266
    [No Abstract]   [Full Text] [Related]  

  • 28. Deficiencies in the analysis of breast cancer screening data.
    Sickles EA; Kopans DB
    J Natl Cancer Inst; 1993 Oct; 85(20):1621-4. PubMed ID: 8179650
    [No Abstract]   [Full Text] [Related]  

  • 29. NCI replaces guidelines with statement of evidence.
    Volkers N
    J Natl Cancer Inst; 1994 Jan; 86(1):14-5. PubMed ID: 8271276
    [No Abstract]   [Full Text] [Related]  

  • 30. NCI board votes to keep mammography guidelines.
    Marwick C
    JAMA; 1993 Dec; 270(23):2783. PubMed ID: 8133600
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current controversy on the effectiveness of mammographic screening for breast cancer in western nations].
    Kuriyama S; Tsuji I
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):158-62. PubMed ID: 14997744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Institutes of Health/National Cancer Institute consensus development meeting on breast cancer screening: issues and recommendations.
    J Natl Cancer Inst; 1978 Jun; 60(6):1519-21. PubMed ID: 580621
    [No Abstract]   [Full Text] [Related]  

  • 33. Rejoinder to Elwood's reply.
    Kopans DB
    Online J Curr Clin Trials; 1993 Apr; Doc No 47():[1069 words; 5 paragraphs]. PubMed ID: 8306004
    [No Abstract]   [Full Text] [Related]  

  • 34. Older women unaware of increased breast cancer risk.
    Cancer Pract; 2000; 8(2):57. PubMed ID: 11898176
    [No Abstract]   [Full Text] [Related]  

  • 35. A different view on what is known about breast screening and the Canadian National Breast Screening Study.
    Baines CJ
    Cancer; 1994 Aug; 74(4):1207-11. PubMed ID: 8055439
    [No Abstract]   [Full Text] [Related]  

  • 36. [Screening for breast cancer: scientific evidence and the media].
    Castells X; Borràs JM
    Gac Sanit; 2000; 14(2):97-9. PubMed ID: 11203055
    [No Abstract]   [Full Text] [Related]  

  • 37. NCI changes its stance on mammography.
    Marwick C
    JAMA; 1994 Jan; 271(2):96. PubMed ID: 8264075
    [No Abstract]   [Full Text] [Related]  

  • 38. The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy.
    Kaluzny AD; Rimer B; Harris R
    J Natl Cancer Inst; 1994 Jun; 86(12):901-3. PubMed ID: 8196079
    [No Abstract]   [Full Text] [Related]  

  • 39. Overview of the National Cancer Institute breast cancer screening consortium projects.
    Haynes SG
    Womens Health Issues; 1992; 2(4):173-4. PubMed ID: 1486279
    [No Abstract]   [Full Text] [Related]  

  • 40. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.